Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review
Authors
Keywords
Rheumatoid arthritis, Anti-citrullinated peptide antibodies, ACPA, Biological therapy, Review literature, Treatment outcome
Journal
RHEUMATOLOGY INTERNATIONAL
Volume 36, Issue 8, Pages 1043-1063
Publisher
Springer Nature
Online
2016-06-06
DOI
10.1007/s00296-016-3506-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SAT0207 Comparison of Efficacies of Abatacept and Tocilizumab in Patients with Rheumatoid Arthritis by a Propensity-Score Matching
- (2015) S. Kubo et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial
- (2015) Jeremy Sokolove et al. ANNALS OF THE RHEUMATIC DISEASES
- Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis
- (2015) Luisa Lindenberg et al. ARTHRITIS RESEARCH & THERAPY
- Autoantibodies in Prediction of the Development of Rheumatoid Arthritis Among Healthy Relatives of Patients With the Disease
- (2015) Cesar Ramos-Remus et al. Arthritis & Rheumatology
- Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA
- (2014) Carolin Hecht et al. ANNALS OF THE RHEUMATIC DISEASES
- Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period
- (2014) Paul Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Anticyclic Citrullinated Protein Antibodies Are Implicated in the Development of Cardiovascular Disease in Rheumatoid Arthritis
- (2014) Nuria Barbarroja et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study
- (2014) Hubert G Nüßlein et al. BMC MUSCULOSKELETAL DISORDERS
- Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis
- (2014) Jose U. Scher et al. CURRENT OPINION IN RHEUMATOLOGY
- Predictors of Response to TNF Antagonists
- (2014) Eva Salgado et al. CURRENT PHARMACEUTICAL DESIGN
- High anti-CCP antibody titres predict good response to rituximab in patients with active rheumatoid arthritis
- (2014) Anaïs Gardette et al. JOINT BONE SPINE
- Independent Relationship of Osteoprotegerin Concentrations with Endothelial Activation and Carotid Atherosclerosis in Patients with Severe Rheumatoid Arthritis
- (2014) P. H. Dessein et al. JOURNAL OF RHEUMATOLOGY
- A Metaanalysis of the Increased Risk of Rheumatoid Arthritis-related Pulmonary Disease as a Result of Serum Anticitrullinated Protein Antibody Positivity
- (2014) J. Zhu et al. JOURNAL OF RHEUMATOLOGY
- Abatacept Reduces Levels of Switched Memory B Cells, Autoantibodies, and Immunoglobulins in Patients with Rheumatoid Arthritis
- (2014) M. Scarsi et al. JOURNAL OF RHEUMATOLOGY
- Osteoprotegerin Concentrations Relate Independently to Established Cardiovascular Disease in Rheumatoid Arthritis
- (2014) R. Lopez-Mejias et al. JOURNAL OF RHEUMATOLOGY
- Prevalence and predictive value of anti-cyclic citrullinated protein antibodies for future development of rheumatoid arthritis in early undifferentiated arthritis
- (2014) Yasser Emad et al. Modern Rheumatology
- Decrease in the levels of anti-cyclic citrullinated peptide antibody in Japanese patients with rheumatoid arthritis who responded to anti-tumor necrosis factor-α
- (2014) Sachiko Onishi et al. Modern Rheumatology
- Disease activity score 28 may overestimate the remission induction of rheumatoid arthritis patients treated with tocilizumab: comparison with the remission by the clinical disease activity index
- (2014) Shin-ya Kawashiri et al. Modern Rheumatology
- The Status of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody Are Not Associated with the Effect of Anti-TNFα Agent Treatment in Patients with Rheumatoid Arthritis: A Meta-Analysis
- (2014) Qianwen Lv et al. PLoS One
- Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study
- (2014) C. A. Kelly et al. RHEUMATOLOGY
- Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study
- (2014) I. Hafstrom et al. BMJ Open
- Rituximabe para o tratamento da artrite reumatoide: Revisão sistemática
- (2014) Lívia Lovato Pires de Lemos et al. Revista Brasileira De Reumatologia
- Rheumatoid Factor as a Potentiator of Anti-Citrullinated Protein Antibody-Mediated Inflammation in Rheumatoid Arthritis
- (2014) Jeremy Sokolove et al. Arthritis & Rheumatology
- Systematic Review: Accuracy of Anti–Citrullinated Peptide Antibodies for Diagnosing Rheumatoid Arthritis
- (2013) Penny F. Whiting ANNALS OF INTERNAL MEDICINE
- Review on the Influence of Protocol Design on Clinical Outcomes in Rheumatoid Arthritis Treated with Rituximab
- (2013) Shawn Shetty et al. ANNALS OF PHARMACOTHERAPY
- Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies
- (2013) Arnd Kleyer et al. ANNALS OF THE RHEUMATIC DISEASES
- Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis
- (2013) Mikael Brink et al. ARTHRITIS AND RHEUMATISM
- Brief Report: Citrullination Within the Atherosclerotic Plaque: A Potential Target for the Anti-Citrullinated Protein Antibody Response in Rheumatoid Arthritis
- (2013) Jeremy Sokolove et al. ARTHRITIS AND RHEUMATISM
- Arthritis and bone loss
- (2013) Arnd Kleyer et al. CURRENT OPINION IN RHEUMATOLOGY
- Adaptive immunity in rheumatoid arthritis
- (2013) Lars Klareskog et al. CURRENT OPINION IN RHEUMATOLOGY
- Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: Systematic review and meta-analysis of observational studies
- (2013) Eva Salgado et al. JOINT BONE SPINE
- Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition
- (2013) Khaled Amara et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Longterm Effects of Rituximab on B Cell Counts and Autoantibody Production in Rheumatoid Arthritis: Use of High-sensitivity Flow Cytometry for More Sensitive Assessment of B Cell Depletion
- (2013) A. Vancsa et al. JOURNAL OF RHEUMATOLOGY
- Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice
- (2013) Yves-Marie Pers et al. RHEUMATOLOGY
- Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis
- (2013) R.J. Maneiro et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study
- (2013) Nicola Bizzaro et al. ARTHRITIS RESEARCH & THERAPY
- Smoking and overweight determine the likelihood of developing rheumatoid arthritis
- (2012) Maria J H de Hair et al. ANNALS OF THE RHEUMATIC DISEASES
- A prediction rule for the development of arthritis in seropositive arthralgia patients
- (2012) Lotte Arwen van de Stadt et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis
- (2012) John D Isaacs et al. ANNALS OF THE RHEUMATIC DISEASES
- Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the ‘AMC-Senshu’ method
- (2012) Jing Shi et al. ANNALS OF THE RHEUMATIC DISEASES
- Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry
- (2012) J E Gottenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
- (2012) Michael E. Weinblatt et al. ARTHRITIS AND RHEUMATISM
- Cardiovascular Risk in Rheumatoid Arthritis
- (2012) Eugenia Gkaliagkousi et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
- (2012) Ulrike Harre et al. JOURNAL OF CLINICAL INVESTIGATION
- The influence of ACPA status and characteristics on the course of RA
- (2012) Annemiek Willemze et al. Nature Reviews Rheumatology
- Autoantibody Epitope Spreading in the Pre-Clinical Phase Predicts Progression to Rheumatoid Arthritis
- (2012) Jeremy Sokolove et al. PLoS One
- Predictive Factors of Rituximab Response in Rheumatoid Arthritis: Results From a French University Hospital
- (2012) M. Couderc et al. ARTHRITIS CARE & RESEARCH
- Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
- (2011) M. H. Buch et al. ANNALS OF THE RHEUMATIC DISEASES
- Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries
- (2011) K. Chatzidionysiou et al. ANNALS OF THE RHEUMATIC DISEASES
- Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomes
- (2011) J. Bathon et al. ANNALS OF THE RHEUMATIC DISEASES
- Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE
- (2011) Paul P Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: A six-month, national, multicenter, open-label study
- (2011) Jérémie Sellam et al. ARTHRITIS AND RHEUMATISM
- Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment
- (2011) Preeti Lal et al. ARTHRITIS AND RHEUMATISM
- Immunotherapeutic implication of IL-6 blockade
- (2011) Toshio Tanaka et al. Immunotherapy
- Second Generation Automated Anti-CCP Test Better Predicts the Clinical Diagnosis of Rheumatoid Arthritis
- (2011) Mohamed Elrefaei et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Are the anti-cyclic citrullinated peptide antibodies independent predictors of myocardial involvement in patients with active rheumatoid arthritis?
- (2011) D. Marasovic-Krstulovic et al. RHEUMATOLOGY
- Serum anti-cyclic citrullinated peptide antibodies may predict disease activity in rheumatoid arthritis
- (2011) Kamal Esalatmanesh et al. RHEUMATOLOGY INTERNATIONAL
- The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years
- (2011) Licia Maria Henrique da Mota et al. RHEUMATOLOGY INTERNATIONAL
- Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients
- (2011) G Hjeltnes et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis
- (2011) Heidi Kokkonen et al. ARTHRITIS RESEARCH & THERAPY
- Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))
- (2010) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity
- (2010) T. G. Kormelink et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities
- (2010) A. Ioan-Facsinay et al. ANNALS OF THE RHEUMATIC DISEASES
- Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial
- (2010) P. P. Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: Implications for autoimmunity in rheumatoid arthritis
- (2010) Natalia Wegner et al. ARTHRITIS AND RHEUMATISM
- Reduced-dose rituximab in rheumatoid arthritis: Efficacy depends on degree of B cell depletion
- (2010) Edward M. Vital et al. ARTHRITIS AND RHEUMATISM
- The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis
- (2010) Mohammed Z Cader et al. BMC MUSCULOSKELETAL DISORDERS
- Efficacy and Safety of Retreatment in Patients with Rheumatoid Arthritis with Previous Inadequate Response to Tumor Necrosis Factor Inhibitors: Results from the SUNRISE Trial
- (2010) P. J. MEASE et al. JOURNAL OF RHEUMATOLOGY
- Anti-cyclic citrullinated peptide antibody predicts functional disability in patients with rheumatoid arthritis in a large prospective observational cohort in Japan
- (2010) Kumi Shidara et al. RHEUMATOLOGY INTERNATIONAL
- Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies
- (2010) Tracey M. Farragher et al. ARTHRITIS CARE & RESEARCH
- Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: Two faces of the same coin
- (2010) Elena Bartoloni et al. ARTHRITIS CARE & RESEARCH
- The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis
- (2010) Maria D Mjaavatten et al. ARTHRITIS RESEARCH & THERAPY
- Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor
- (2010) Alejandro Balsa et al. ARTHRITIS RESEARCH & THERAPY
- Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis
- (2009) L. Damjanovska et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)
- (2009) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
- (2009) M J L Peters et al. ANNALS OF THE RHEUMATIC DISEASES
- Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis
- (2009) Francisco Javier López-Longo et al. ARTHRITIS AND RHEUMATISM
- Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis
- (2009) Michael P. M. van der Linden et al. ARTHRITIS AND RHEUMATISM
- Rheumatoid arthritis
- (2009) Lars Klareskog et al. LANCET
- Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis
- (2009) Raimon Sanmartí et al. ARTHRITIS RESEARCH & THERAPY
- Antibodies to cyclic citrullinated protein and erythrocyte sedimentation rate predict hand bone loss in patients with rheumatoid arthritis of short duration: a longitudinal study
- (2009) Pernille Bøyesen et al. ARTHRITIS RESEARCH & THERAPY
- Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response
- (2009) Magda Nakou et al. ARTHRITIS RESEARCH & THERAPY
- Progression of joint damage in early rheumatoid arthritis: Association with HLA–DRB1, rheumatoid factor, and anti–citrullinated protein antibodies in relation to different treatment strategies
- (2008) J. K. de Vries-Bouwstra et al. ARTHRITIS AND RHEUMATISM
- Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies
- (2008) J. Antonio Aviña-Zubieta et al. ARTHRITIS AND RHEUMATISM
- Atherosclerosis in Autoimmune Rheumatic Diseases—Mechanisms and Clinical Findings
- (2008) Hasya Zinger et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- The relationship between anti‐cyclic citrullinated peptide and bone mineral density and radiographic damage in patients with rheumatoid arthritis
- (2008) H. Guler et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Carotid Intima-Media Thickness Predicts the Development of Cardiovascular Events in Patients with Rheumatoid Arthritis
- (2008) Carlos Gonzalez-Juanatey et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab
- (2008) Sanna Rosengren et al. ARTHRITIS RESEARCH & THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started